<DOC>
	<DOCNO>NCT02984384</DOCNO>
	<brief_summary>The purpose study investigate effectiveness Low Molecular Weight Heparin ( LMWH ) compare Aspirin prevent death clinically important pulmonary blood clot patient sustain trauma .</brief_summary>
	<brief_title>PREVENTion Clot Orthopaedic Trauma</brief_title>
	<detailed_description>In study efficacy Low Molecular Weight Heparin ( LMWH ) ( Enoxaparin ) compare Aspirin use prevent death clinically important blood clot lungs patient sustain trauma investigate . The following comparison aspirin LMWH describe specific aim : Specific Aim 1 : Assess proportion patient sustain death , clinically significant pulmonary embolism , complication orthopaedic trauma treat injectable LMWH compare treat aspirin . Hypothesis 1a : The mortality rate non-inferior aspirin group Hypothesis 1b : The rate clinically significant PE non-inferior aspirin group Hypothesis 1c : The rate complication superior ( i.e. , low ) aspirin group Specific Aim 2 : Assess satisfaction care orthopaedic trauma patient treat injectable LMWH compare treat aspirin Hypothesis2a : Satisfaction superior aspirin group Specific Aim 3 : Document pocket patient cost orthopaedic trauma patient treat injectable LMWH compare treat aspirin Hypothesis3a : Out pocket cost low aspirin group Specific Aim 4 : Examine proportion minor clot event less important patient ( clot proximal leg , incidental PE ) orthopaedic trauma patient treat injectable LMWH compare treat aspirin . Hypothesis4a : The rate non-inferior aspirin group Specific Aim 5 : Examine proportion minor clot event less important patient ( clot proximal leg , incidental PE ) orthopaedic trauma patient treat injectable LMWH compare treat aspirin . Hypothesis 5a : The rate non-inferior aspirin group .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>Trauma patient increase risk blood clot orthopaedic traumatic injury ( operatively treat extremity injury pelvis acetabulum fracture treat either operatively non operatively ) prophylactic blood thinner regimen would standard care institution . 18 year old Patients require prophylactic blood thinner standard practice Patients already long term blood thinner ( participant lowdose aspirin platelet inhibitor Plavix Aggrenox NOT exclude ) require therapeutic ( opposed prophylactic ) blood thinner acute issue blood clot last 6 month ) Patients receive either study medication due allergy ( history heparin induce thrombocytopenia , allergy aspirin , NSAIDs ) medical contraindication blood thinner Patients high dose aspirin ( &gt; 81 mg day high ) medical reason treat high dose aspirin Patients underlie chronic clotting disorder ( i.e . Factor V Leiden , hyperhomocysteinemia , Protein C S deficiency ) require full dose anticoagulation contraindication venous thromboembolism chemoprophylaxis ; End stage renal disease impair creatinine clearance &lt; 30 ml/min time randomization ( note : creatinine clearance need document prescribing physician would order medication without test SOC ) Pregnant lactate patient ; Patients contraindicate reason either medicine Prisoners Patients speak either English Spanish Patients may exclude reason discretion treat physician ; reason exclusion must document screen form . Patients must enrol prior receive 2 dos LMWH Aspirin initial prophylaxis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Trauma</keyword>
	<keyword>Blood clot</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Deep Vein Thrombosis</keyword>
	<keyword>Thromboprophylaxis</keyword>
	<keyword>Blood clot prevention</keyword>
	<keyword>trauma patient</keyword>
</DOC>